SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

30 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 4762.33 millions rose by 36.55% from Rs. 3487.53 millions.The Total Profit for the quarter ended March 2022 of Rs. 116.58 millions grew from Rs.-409.60 millionsOperating profit surged to 496.70 millions from the corresponding previous quarter of 302.61 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 4762.33 3487.53 36.55 16682.56 15428.96 8.12 16682.56 15428.96 8.12
Other Income 5.20 10.19 -48.97 112.93 27.22 314.88 112.93 27.22 314.88
PBIDT 496.70 302.61 64.14 1701.31 1129.49 50.63 1701.31 1129.49 50.63
Interest 174.31 256.46 -32.03 788.10 1120.32 -29.65 788.10 1120.32 -29.65
PBDT 322.39 -207.00 -255.74 913.21 -243.98 -474.30 913.21 -243.98 -474.30
Depreciation 142.57 150.08 -5.00 569.68 602.53 -5.45 569.68 602.53 -5.45
PBT 179.82 -357.08 -150.36 343.53 -846.51 -140.58 343.53 -846.51 -140.58
TAX 63.24 52.52 20.41 90.34 -115.04 -178.53 90.34 -115.04 -178.53
Deferred Tax 63.24 -33.34 -289.68 90.34 -200.90 -144.97 90.34 -200.90 -144.97
PAT 116.58 -409.60 -128.46 253.19 -731.47 -134.61 253.19 -731.47 -134.61
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 9.07 7.43 22.12 8.84 6.41 37.98 8.84 6.41 37.98

Nectar Lifesciences Share Price

12.26 0.32 (2.68%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×